Clinical Trials · NCT01225055

Effect of Teriparatide, Vibration and the Combination on Bone Mass and Bone Architecture in Chronic Spinal Cord Injury

CompletedPhase 2Teriparatide (Approved)
Phase
Phase 2
Recruitment status
Completed
Sponsor
Thomas J. Schnitzer
Enrollment
60
Start date
Oct 2010
Locations
2 sites, United States
Primary endpoint
Bone Mineral Density BMD of the Total Hip as Assessed by DXA.
View Teriparatide compound reference